Skip to main content
. 2010 Feb 11;28(16):2887–2894. doi: 10.1016/j.vaccine.2010.01.062

Table 6.

Protective effects in 3-week-old SPF chickens immunized with H120 and K2p170 against challenge with IBV isolates representing the two major Korean IBV genogroups.

IBV strain immunizeda Genogroup of challenge virus IBV strain of challenge virusb No. of challenge virus isolated/no. of challengedc
Trachea
Kidney
Control Vaccinated Control Vaccinated
H120 Korean group I Mass 41 10/10 0/10*** 10/10 0/10***
K571/99 9/10 5/10 1/10 0/10
K107/04 7/10 4/9 0/10 0/9



Korean group II K2parent 10/10 3/10** 10/10 7/10
KM91 10/10 5/10 8/10 4/10
K1277/03 10/10 8/10 9/10 8/10



K2p170 Korean group I Mass 41 10/10 2/10*** 10/10 0/10***
K571/99 9/10 0/10***, 1/10 1/10
K107/04 7/10 2/10 0/10 0/10



Korean group II K2parent 10/10 1/10*** 10/10 1/10***,
KM91 10/10 4/10* 8/10 0/10***
K1277/03 10/10 3/8** 9/10 0/8***,††
a

Three-week-old chickens were immunized with IBV, H120 and K2p170 (103.0EID50/bird) via the intraocular route.

b

At 3 weeks post-immunization, all birds were challenged with 104.5EID50 of six Korean IBV strains via the intraocular route.

c

Five days after challenge, protection was evaluated by the absence of challenge virus in the kidney and trachea.

*

p < 0.01, by Fisher's exact test, compared to non-vaccinated control group.

**

p < 0.005, by Fisher's exact test, compared to non-vaccinated control group.

***

p < 0.001, by Fisher's exact test, compared to non-vaccinated control group.

p < 0.01, by Fisher's exact test, compared to the H120-vaccinated group.

††

p < 0.005, by Fisher's exact test, compared to the H120-vaccinated group.